AFP and liver cancer: CA19-9 was found to be a sensitive and specific marker of pancreatic cancer.[14] From our results, it was observed that the expression of TAP was correlated with that of AFP in liver cancer (P < .05) (Table 5), suggesting the promise of TAP as an alternative marker for liver cancer.